2 posts found
Ultrahuman Ring Pro just cleared US customs after an Oura patent block and is selling at $479 with no subscription. That price validates Pulsyn's entire thesis: on-device health tracking should not cost more than a flagship smartphone.
Oura filed for its $11 billion IPO with 5 million subscribers and $2 billion in projected revenue. The catch: its core business model is a subscription paywall on health data that competitors already offer for free, sitting on top of a canceled Pentagon contract and an active class-action lawsuit.
